Tech Company Financing Transactions
RTI Biologics Funding Round
RTI Biologics closed a $50 million funding round on 7/18/2013. Backers included Water Street Healthcare Partners.
Transaction Overview
Company Name
Announced On
7/18/2013
Transaction Type
Venture Equity
Amount
$50,000,000
Round
Undisclosed
Investors
Water Street Healthcare Partners (Curt Selquist)
Proceeds Purpose
Proceeds purposes were not disclosed, however the company also announced the acquisition of Pioneer Surgical Technology.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
11621 Research Cir.
Alachua, FL 32615
USA
Alachua, FL 32615
USA
Phone
Website
Email Address
Overview
RTI Biologics, Inc. is a leading provider of sterile biological implants for surgeries around the world, with a commitment to advancing science, safety and innovation.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Camille Farhat
Chief Financial Officer
Jonathon Singer
Chief Medical Officer
Lennox Archibald
Vice President
Julius Aviza
Vice President
Enrico Sangiorgio
Vice President
Olivier Visa
VP - Human Resources
Paul Montague
VP - Operations
John Varela
VP - R & D
Tony Lemus
Browse more venture capital transactions:
Prev: 7/18/2013: CrowdOptic venture capital transaction
Next: 7/19/2013: Digital Angel venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs